Target intelligence / Profile preview

Cellular zinc-dependent enzymes

Molecular classification
Enzyme, Metalloprotein
01

Overview

Cellular zinc-dependent enzymes is not a specific molecular target, but rather a broad group encompassing hundreds of enzymes that require zinc ions (Zn²⁺) as essential cofactors for their catalytic, structural, or regulatory activity. These enzymes operate across diverse biological processes, including metabolism, gene expression, signaling, and tissue remodeling. Notable examples include matrix metalloproteinases (involved in tissue degradation and cancer metastasis), angiotensin-converting enzyme (regulator of blood pressure), alcohol dehydrogenase (alcohol metabolism), carbonic anhydrase (acid-base balance), and phosphodiesterases (signal transduction). Zinc-dependent enzymes are critical to health, and dysregulation or inhibition can lead to diverse pathologies. As a group, they are not a drug target but contain many validated targets; thus, no canonical abbreviation or name applies to the collective entity. Note: Cellular zinc-dependent enzymes is too broad and non-specific to be a valid single target. It describes many unrelated proteins unified only by the requirement for Zn²⁺ for activity, spanning multiple molecular families and biological functions. For structured data, individual zinc-dependent enzymes (like "Matrix metalloproteinase 9" or "Angiotensin-converting enzyme") should be treated as separate targets, each with specific properties.

Other names
Zinc-dependent enzymeCellular zinc enzymeZinc metalloenzymeCellular metalloenzyme (zinc-dependent)Zinc-dependent protein
02

Mechanism of action

Inhibition of catalytic activity by blocking the zinc-binding site; Chelation of zinc ion from the enzyme active site, causing enzyme inactivation; Competitive or non-competitive inhibition depending on the specific enzyme; Some drugs act as substrate analogs or block substrate access to the zinc-containing catalytic center.

03

Biological functions

Catalysis of diverse metabolic reactions (e.g., DNA synthesis, RNA processing, protein degradation, small molecule metabolism, detoxification)Signal transduction (e.g., via protein kinase C, or cyclic nucleotide signaling enzymes)Regulation of gene expression (e.g., by transcription factors with zinc finger domains)Cell proliferation, differentiation, and apoptosisImmune response regulation and modulation
04

Disease associations

Cancer (e.g., via matrix metalloproteinases, dysregulated proliferation)Inflammation (e.g., through regulation of cytokine signaling)Neurodegenerative disease (e.g., ZnPKC signaling, neuronal apoptosis)Cardiovascular disease (e.g., angiotensin-converting enzyme)Infectious disease (role in immune cell function)Other (metabolic diseases, diabetes via ZnT8 in the pancreas)
05

Safety considerations

Off-target inhibition can disrupt essential metabolic pathways leading to toxicitySystemic chelation of zinc can cause immune suppression, poor wound healing, and neurological effectsSome zinc-dependent enzymes have overlapping substrate specificity, increasing the risk of undesired cross-inhibitionIndividual inhibitors (e.g., ACE inhibitors, MMP inhibitors) have specific adverse effect profiles, including blood pressure changes, risk of infection, or impaired tissue repair
06

Interacting drugs

Angiotensin-converting enzyme (ACE) inhibitors (e.g., captopril, enalapril)

4 more in the full profile.

07

Biomarkers

Tissue or plasma levels of matrix metalloproteinases (MMPs) for cancer and inflammationActivity assays of alcohol dehydrogenase, carboxypeptidase, alkaline phosphatase, etc.ZnT8 autoantibody status in type 1 diabetes (via the zinc transporter for insulin granules)Null for a single cross-enzyme biomarker

Beyond the preview

Go deeper on Cellular zinc-dependent enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular zinc-dependent enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call